(Q39016341)

English

A moderate static magnetic field enhances TRAIL-induced apoptosis by the inhibition of Cdc2 and subsequent downregulation of survivin in human breast carcinoma cells

scientific article published on 20 February 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 September 2017

A moderate static magnetic field enhances TRAIL-induced apoptosis by the inhibition of Cdc2 and subsequent downregulation of survivin in human breast carcinoma cells (English)

1 reference

Europe PubMed Central

8 September 2017

static magnetic field

1 reference

based on heuristic

inferred from title

breast carcinoma

1 reference

based on heuristic

inferred from title

author name string

Tingting Lin

1

1 reference

Europe PubMed Central

8 September 2017

Ling Wan

2

1 reference

Europe PubMed Central

8 September 2017

Xin Qi

3

1 reference

Europe PubMed Central

8 September 2017

Wenlong Shi

4

1 reference

Europe PubMed Central

8 September 2017

Jun Lin

5

1 reference

Europe PubMed Central

8 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

20 February 2014

1 reference

Europe PubMed Central

8 September 2017

Bioelectromagnetics

1 reference

Europe PubMed Central

8 September 2017

35

1 reference

Europe PubMed Central

8 September 2017

5

1 reference

Europe PubMed Central

8 September 2017

337-346

1 reference

Europe PubMed Central

8 September 2017

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FBEM.21849

21 January 2018

Static magnetic fields affect capillary flow of red blood cells in striated skin muscle

1 reference

https://api.crossref.org/works/10.1002%2FBEM.21849

21 January 2018

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

1 reference

https://api.crossref.org/works/10.1002%2FBEM.21849

21 January 2018

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

https://api.crossref.org/works/10.1002%2FBEM.21849

21 January 2018

Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugs.

1 reference

https://api.crossref.org/works/10.1002%2FBEM.21849

21 January 2018

Effects of a moderate-intensity static magnetic field and adriamycin on K562 cells.

1 reference

https://api.crossref.org/works/10.1002%2FBEM.21849

21 January 2018

Survivin expression and targeting in breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FBEM.21849

21 January 2018

Uniform magnetic fields and double-wrapped coil systems: improved techniques for the design of bioelectromagnetic experiments.

1 reference

https://api.crossref.org/works/10.1002%2FBEM.21849

21 January 2018

Static magnetic fields inhibit proliferation and disperse subcellular localization of gamma complex protein3 in cultured C2C12 myoblast cells.

1 reference

https://api.crossref.org/works/10.1002%2FBEM.21849

21 January 2018

TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window.

1 reference

https://api.crossref.org/works/10.1002%2FBEM.21849

21 January 2018

Cyclin A/Cdk2 complexes regulate activation of Cdk1 and Cdc25 phosphatases in human cells

1 reference

https://api.crossref.org/works/10.1002%2FBEM.21849

21 January 2018

A p34(cdc2) survival checkpoint in cancer

1 reference

https://api.crossref.org/works/10.1002%2FBEM.21849

21 January 2018

The receptor for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1002%2FBEM.21849

21 January 2018

The TRAIL to targeted therapy of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FBEM.21849

21 January 2018

Exposure to strong static magnetic field slows the growth of human cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FBEM.21849

21 January 2018

Effects of static magnetic field on human leukemic cell line HL-60.

1 reference

https://api.crossref.org/works/10.1002%2FBEM.21849

21 January 2018

Static magnetic fields impair angiogenesis and growth of solid tumors in vivo

1 reference

https://api.crossref.org/works/10.1002%2FBEM.21849

21 January 2018

Static magnetic fields induce blood flow decrease and platelet adherence in tumor microvessels

1 reference

https://api.crossref.org/works/10.1002%2FBEM.21849

21 January 2018

Static and ELF magnetic fields induce tumor growth inhibition and apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FBEM.21849

21 January 2018

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FBEM.21849

21 January 2018

2-Tellurium-bridged β-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1093/CARCIN/BGQ234

Identifiers

10.1002/BEM.21849

1 reference

Europe PubMed Central

8 September 2017

1 reference

Europe PubMed Central

8 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39016341&oldid=2045167524"